ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2504

Variables Associated with In-Hospital Mortality in Adult Eosinophilic Granulomatosis with Polyangiitis from the National Inpatient Sample Database 2017-2021

Anuya Natu1, Isadora Small2, Shilpa Arora3 and Augustine Manadan4, 1John H Stroger, Jr. Hospital of Cook County, Chicago, IL, 2The Latin School of Chicago, Chicago, IL, 3Cook County Hospital, Chicago, IL, 4Rush University Medical Center, Chicago, IL

Meeting: ACR Convergence 2025

Keywords: ANCA, ANCA associated vasculitis, Eosinophilic Granulomatosus with Polyangiitis (Churg-Strauss), Mortality, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2504–2523) Vasculitis – ANCA-Associated Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare systemic vasculitis that can lead to significant morbidity and mortality. This study aims to evaluate the demographic, clinical, and hospital-related characteristics associated with in-hospital mortality among EGPA hospitalizations using a claims-based US national database.

Methods: A retrospective analysis of the National Inpatient Sample (NIS) database from 2017 – 2021 was conducted to identify adult hospitalizations with a primary or secondary diagnosis of EGPA (ICD 10: M30.1). Descriptive statistics were used to compare patients discharged alive and those who suffered in-hospital mortality. All variables with p ≤ 0.2 in the univariable screen were included in a multivariable logistic regression model to assess independent predictors of in-hospital death. p ≤ 0.05 was considered significant in multivariable analysis. Cells of data containing hospitalization records with a value of 1 to 10 were not reported to protect hospital privacy as per the Healthcare Cost and Utilization Project (HCUP) data service agreement.

Results: A total of 9,095 hospitalizations for EGPA were identified, with an in-hospital mortality rate of 2.9% (n = 265) (Table 1). Patients who died in-hospital were older (median age 69 vs. 63 years ; p = 0.018), had a higher median Charlson Comorbidity Index (CCI) (3 vs. 2; p = 0.01), higher acute kidney injury (AKI) (66.0% vs. 19.9%; p < 0.001), higher alveolar hemorrhage (5.7% vs. 0.8%; p < 0.001), higher concurrent infection (79.2% vs. 46.2%; p < 0.001), higher heart failure (37.7% vs. 22.9%; p = 0.012), longer median hospital length of stay (10 vs. 4 days; p < 0.001), and higher median total hospital charges ($154,087 vs. $43,916; p < 0.001). The variables from the univariable screen showing an association with in-hospital mortality were age, male sex, Medicare insurance, Medicaid insurance, private insurance, CCI, AKI, alveolar hemorrhage, heart failure, hemophagocytic lymphohistiocytosis, infection, and myocardial infarction (Table 2).In multivariable regression analysis, independent predictors of in-hospital mortality included AKI (OR 4.81; 95% CI 2.50 - 9.25), alveolar hemorrhage (OR 6.92; 95% CI 1.47 - 32.46), and infection (OR 3.56; 95% CI 1.81 - 7.01) (Table 3). Age, sex, insurance type, and comorbidity burden were not independent predictors of in-hospital death in EGPA.

Conclusion: In this large, nationally representative cohort, EGPA hospitalizations had a 2.9% in-hospital mortality rate. AKI, alveolar hemorrhage, and infection were strong independent predictors of mortality. These findings highlight the need for early recognition and management of these complications to improve outcomes in hospitalized EGPA patients.

Supporting image 1Table 1: Descriptive Characteristics of Adult Hospitalizations with EGPA from the National Inpatient Sample Database 2017-2021 (n=9,095).

Abbreviations: AKI= Acute Kidney Injury; CCI= Charlson Comorbidity Index; EGPA=Eosinophilic Granulomatosis with Polyangiitis; HLH= Hemophagocytic Lymphohistiocytosis; HF= Heart Failure; IQR=interquartile range; LOS=Length of Stay; n=number; NIS= National Inpatient Sample Database; NR = not reported as below permitted reporting threshold (≤10 cases); PI=Pacific Islander.

Supporting image 2Table 2: Univariable Logistic Regression for In-hospital Death for EGPA from NIS 2017-2021.

Abbreviations: AKI= Acute Kidney Injury; CCI= Charlson Comorbidity Index; EGPA=Eosinophilic Granulomatosis with Polyangiitis; HLH= Hemophagocytic Lymphohistiocytosis; HF= Heart Failure; NIS= National Inpatient Sample Database.

*Univariable analysis was not conducted for Native American, Self Pay, No Charge and Myocarditis as there were no observed deaths in that category.

Supporting image 3Table 3: Multivariable Logistic Regression for In-hospital Death for EGPA from NIS 2017-2021.

Abbreviations: AKI= Acute Kidney Injury; CCI= Charlson Comorbidity Index; EGPA= Eosinophilic Granulomatosis with Polyangiitis; HLH= Hemophagocytic Lymphohistiocytosis; HF= Heart Failure; NIS= National Inpatient Sample Database;


Disclosures: A. Natu: None; I. Small: None; S. Arora: None; A. Manadan: None.

To cite this abstract in AMA style:

Natu A, Small I, Arora S, Manadan A. Variables Associated with In-Hospital Mortality in Adult Eosinophilic Granulomatosis with Polyangiitis from the National Inpatient Sample Database 2017-2021 [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/variables-associated-with-in-hospital-mortality-in-adult-eosinophilic-granulomatosis-with-polyangiitis-from-the-national-inpatient-sample-database-2017-2021/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/variables-associated-with-in-hospital-mortality-in-adult-eosinophilic-granulomatosis-with-polyangiitis-from-the-national-inpatient-sample-database-2017-2021/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology